Reinhilde Spatscheck

ProBioGen AG operates as a contract development and manufacturing organization. It specializes in cell line engineering, process development, and GMP manufacturing of biopharmaceuticals. The firm offers services such as cell line development, process development, manufacturing programs, physio-chemical analyses, and cell-based assays. The company was founded by Uwe Marx on June 13, 1994 and is headquartered in Berlin, Germany.

BWK GmbH Unternehmensbeteiligungsgesellschaft is part of the private equity arm and a majority-owned subsidiary of LBBW-Landesbank Baden-Württemberg, a government-controlled regional bank based in southwestern Germany. Significant minority shareholders include regional financial institutions and insurance companies. Founded in 1990, BWK is headquartered in Stuttgart, Germany. In 2008 the firm merged with BWK Private Equity GmbH.

Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999.

CorCell, Inc. provides umbilical stem cell preservation & cord blood-banking services to use stem cells as future treatments for a variety of diseases and illnesses. The company collects umbilical cord blood stem cells from hospitals in all 50 states and abroad. CorCell has parterships with Maxxim Medical, Kimmel Cancer Center and Independence Blue Cross. CorCell was founded in 1995 and is located in Philadelphia, PA.

Brockhaus Private Equity GmbH (Brockhaus PE) is an independent German private equity firm which was founded in late 1999 by Marco Brockhaus. Headquartered in Frankfurt, Brockhaus PE manages the Brockhaus Private Equity Funds which invest in German and European middle market technology companies.

Affimed NV Niederlassung Deutschland discovers and develops antibody-based therapeutic drugs. The firm generates and develops a pipeline of antibody product candidates based on proprietary technology platform. It offer therapeutic drugs that target autoimmune diseases and tumor cells. The company was founded in 2000 and is headquartered in Heidelberg, Germany.

Biotronik SE & Co. KG researches, develops, manufactures and supplies orthopedic, prosthetic and surgical appliances. It offers products for bradycardia therapy, including pacemakers, leads, and external devices; tachyarrhythmia therapy, such as ICDs, leads, and external devices; ablation and diagnostic catheters. The company was founded by Max Schaldach in 1963 and is headquartered in Berlin, Germany.

Dräger Medical AG & Co. KG manufactures medical equipment. The firm's products include Anesthesia workstations, monitoring systems, enterprise solutions, information technologies, ventilation therapy, home mechanical ventilation, warming therapy, architectural systems, accessories, surgical lighting and video systems. It offers services in the fields of emergency, perioperative, critical, perinatal, and home care. The company was founded in 1889 and is headquartered in Luebeck, Germany.

Tuebingen Scientific Medical GmbH develops, produces and markets instruments and accessories for minimally invasive surgery. The company was founded by Marc O. Schurris in 2001 and is headquartered in Tübingen, Germany.

c-LEcta GmbH operates as a industrial biotechnology company that discovers, optimizes, produces, and sells enzymes for research, development, bio-catalysis, diagnostics, and industrial applications. The firm focuses on the utilization of proteins with catalytic properties. It offers recombinant RNases, exonucleases, alcohol-dehydrogenases, lipases, and proteases for applications in research and development; biocatalysts for the production of chemicals; and starch, cellulose, and hemicellulose hydrolyzing enzymes, as well as lipases and proteases to use as components in detergents and cleaning products for the food and feed industry. The company was founded by Marc Struhalla and Thomas Greiner-St?ffele in 2004 and is headquartered in Leipzig, Germany.

Miracor Medical SA engages in the development and manufacture of medical devices. Its product PICSO (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System has a driving console and associated catheters to improve outcomes for severe heart attack patients. It seeks to increase blood flow to the affected heart tissue, thereby improving the overall heart function after a heart attack. The company was founded by Werner Mohl in May, 2008 and is headquartered in Vienna, Austria.

numares AG develops and markets new analytic and diagnostic tests based on nuclear magnetic resonance spectroscopy. It offers in-vitro-diagnostic tests with the CE marking for high-throughput use in clinical practice and medical research. The firm?s test applications provide valuable information on the disease status of patients in the indication areas of cardiovascular diseases, nephrology and oncology. The company was founded in April 2004 and is headquartered in Regensburg, Germany.

Corscience GmbH & Co. KG operates as established development service provider for international medical technology companies. Its products includes ECG, defibrillation, gas analysis, pulse oximetry and multiparameter. The company was founded by Armin Bolz in 2001 and is headquartered in Erlangen, Germany.

Part of Stadt Malchow, Wohnungsbaugesellschaft mbH Malchow leases residential properties, buildings and apartments. The company is based in Malchow, Germany. The CEO of the German company is Doreen Krusel.

Humedics GmbH operates as a research-based medtech company. It focuses on rapid and precise lover function measurement using LiMax, a breath analysis technology. The company was founded by Martin Stockman, Erwin de Bujizer, and Karsten Heyne in 2009 and is headquartered in Berlin, Germany.

Hytest Oy manufactures biological products. It operates as producer of monoclonal antibodies and antigens for the diagnostic industry. The company was founded in 1994 and is headquartered in Turku, Finland.

NEUWAY Pharma GmbH develops treatments for central nervous system diseases. The firm offers preclinical and clinical development of innovative therapeutics for treatment of orphan brain diseases. The company was founded in April 2014 and is headquartered in Bonn, Germany.

TRI Dental Implants Int. AG develops, manufactures, and distributes dental implants. Its products include soft tissue concept, friction, and bone adaptation, as well as sandblasted, large grit, and acid-etched surface implant systems, vent implant line of products, narrow implants, octa implants, prosthetic portfolio of products, and surgical kits for surgeons. The company was founded in 2010 by Tobias S. Richter and is headquartered in Hünenberg, Switzerland.

Venneos GmbH develops an imaging system for the analysis of biological cells. Its products include CAN-Q station, CAN-Q chip, CAn-Q analyzer and demonstration. The firm technology CAN Spectroscopy, brings cell-based assays to the next level: Label-free and non-invasive readout, analysis on a single cell level and a broad spectrum of detectable and distinguishable cellular effects. The company was founded by David Wehner and Jon H. Lehmann in 2014 and is headquartered in Stuttgart, Germany.

SIS Medical AG develops, produces and distributes products for the treatment of vascular diseases. The firm is improving and prolonging human life within the field of minimal invasive therapy. The company was founded by Willi Zwahlen and Michael Schwage and is headquartered in Winterthur, Switzerland.

BWK-Hora Holding GmbH provides investment services. The private company is based in Stuttgart, Germany. The CEOs are Rainer Miller, Bernd Bergschneider. The German company was founded in 2015.

Ovesco Endoscopy AG is a German research-based medical device company that develops, manufactures, and markets instruments and systems for the treatment of gastrointestinal diseases. Ovesco Endoscopy is based in Tuebingen, DE, and has locations in the USA and France. The private company's hallmark is innovative endoscopic clipping systems, including the OTSC® system for the treatment of gastrointestinal hemorrhage and for endoscopic digestive organ wall closure. The company's portfolio has been expanded by novel resection techniques such as FTRD® and Resect+, and also diagnostic sensor capsules such as the Hemopill®. The company was founded by Marc O. Schurr.